SARcode Biosciences' Grant

SARcode Biosciences raised a round of funding on January 10, 2009. Investors include Qualifying Therapeutic Discovery Project.

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…

Articles about SARcode Biosciences' Grant: